insulin glargine and lixisenatide
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
combination drug
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2016 |
| gptkbp:ATCCode |
A10AE54
|
| gptkbp:brand |
gptkb:Soliqua
Suliqua |
| gptkbp:drugClass |
antidiabetic combination
|
| gptkbp:hasComponent |
gptkb:insulin
gptkb:lixisenatide |
| https://www.w3.org/2000/01/rdf-schema#label |
insulin glargine and lixisenatide
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:usedFor |
gptkb:type_2_diabetes
|
| gptkbp:bfsParent |
gptkb:Soliqua
|
| gptkbp:bfsLayer |
7
|